ICD-10-CM/PCS MS-DRG v38.0 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
ICD-10-CM/PCS MS-DRG v38.0 Definitions Manual |
||||
| Skip to content | |
|
|
| MDC 21 Injuries, Poisonings & Toxic Effects of Drugs |
| Other Procedures for Injuries |
| Page 74 of 74 |
OPERATING ROOM PROCEDURES (continued)
0016070 00DH3ZZ 00RN0JZ 00XL4ZK 01NG3ZZ 021R4JA 02RP0JZ 03180JV 037P45Z 03LA4DZ 03S40ZZ 03VL3DZ 041F4AK 047J3D1 04L64ZZ 04RF0JZ 04V40DZ 05BS3ZZ 05P34MZ 05UR4JZ 06L83DZ 06UC3JZ 07L83DZ 07V23DZ 08CGXZZ 08UH0KZ 09UM3JZ 0BR94JZ 0CRB3JZ 0D18474 0D1H07K 0D9900Z 0DLQ4ZZ 0DRU4KZ 0DUV47Z 0DWD73Z 0FH142Z 0FU73KZ 0HM2XZZ 0JR50JZ 0K8M3ZZ 0KPY4JZ 0KUB07Z 0L9T0ZZ 0LRB4JZ 0LX54ZZ 0MD40ZZ 0NBH3ZZ 0NSG04Z 0PCJ4ZZ 0PP80KZ 0PS804Z 0Q880ZZ 0QHG0CZ 0QPJ37Z 0QS805Z 0QUP3JZ 0RG83J0 0RPK43Z 0RWG3KZ 0SG13J1 0SJK0ZZ 0SPQ47Z 0SWB0KZ 0T164K8 0TLC3ZZ 0TVDXZZ 0UUG77Z 0VUQ8JZ 0WF10ZZ 0WWQ4YZ 0XQ74ZZ 0Y6H0Z1 0YUM0KZ
| 0YUM0KZ | Supplement Right Foot with Nonautologous Tissue Substitute, Open Approach |
| 0YUM47Z | Supplement Right Foot with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUM4JZ | Supplement Right Foot with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUM4KZ | Supplement Right Foot with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUN07Z | Supplement Left Foot with Autologous Tissue Substitute, Open Approach |
| 0YUN0JZ | Supplement Left Foot with Synthetic Substitute, Open Approach |
| 0YUN0KZ | Supplement Left Foot with Nonautologous Tissue Substitute, Open Approach |
| 0YUN47Z | Supplement Left Foot with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUN4JZ | Supplement Left Foot with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUN4KZ | Supplement Left Foot with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUP07Z | Supplement Right 1st Toe with Autologous Tissue Substitute, Open Approach |
| 0YUP0JZ | Supplement Right 1st Toe with Synthetic Substitute, Open Approach |
| 0YUP0KZ | Supplement Right 1st Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUP47Z | Supplement Right 1st Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUP4JZ | Supplement Right 1st Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUP4KZ | Supplement Right 1st Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUQ07Z | Supplement Left 1st Toe with Autologous Tissue Substitute, Open Approach |
| 0YUQ0JZ | Supplement Left 1st Toe with Synthetic Substitute, Open Approach |
| 0YUQ0KZ | Supplement Left 1st Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUQ47Z | Supplement Left 1st Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUQ4JZ | Supplement Left 1st Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUQ4KZ | Supplement Left 1st Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUR07Z | Supplement Right 2nd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUR0JZ | Supplement Right 2nd Toe with Synthetic Substitute, Open Approach |
| 0YUR0KZ | Supplement Right 2nd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUR47Z | Supplement Right 2nd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUR4JZ | Supplement Right 2nd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUR4KZ | Supplement Right 2nd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUS07Z | Supplement Left 2nd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUS0JZ | Supplement Left 2nd Toe with Synthetic Substitute, Open Approach |
| 0YUS0KZ | Supplement Left 2nd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUS47Z | Supplement Left 2nd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUS4JZ | Supplement Left 2nd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUS4KZ | Supplement Left 2nd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUT07Z | Supplement Right 3rd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUT0JZ | Supplement Right 3rd Toe with Synthetic Substitute, Open Approach |
| 0YUT0KZ | Supplement Right 3rd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUT47Z | Supplement Right 3rd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUT4JZ | Supplement Right 3rd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUT4KZ | Supplement Right 3rd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUU07Z | Supplement Left 3rd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUU0JZ | Supplement Left 3rd Toe with Synthetic Substitute, Open Approach |
| 0YUU0KZ | Supplement Left 3rd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUU47Z | Supplement Left 3rd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUU4JZ | Supplement Left 3rd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUU4KZ | Supplement Left 3rd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUV07Z | Supplement Right 4th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUV0JZ | Supplement Right 4th Toe with Synthetic Substitute, Open Approach |
| 0YUV0KZ | Supplement Right 4th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUV47Z | Supplement Right 4th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUV4JZ | Supplement Right 4th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUV4KZ | Supplement Right 4th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUW07Z | Supplement Left 4th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUW0JZ | Supplement Left 4th Toe with Synthetic Substitute, Open Approach |
| 0YUW0KZ | Supplement Left 4th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUW47Z | Supplement Left 4th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUW4JZ | Supplement Left 4th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUW4KZ | Supplement Left 4th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUX07Z | Supplement Right 5th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUX0JZ | Supplement Right 5th Toe with Synthetic Substitute, Open Approach |
| 0YUX0KZ | Supplement Right 5th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUX47Z | Supplement Right 5th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUX4JZ | Supplement Right 5th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUX4KZ | Supplement Right 5th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUY07Z | Supplement Left 5th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUY0JZ | Supplement Left 5th Toe with Synthetic Substitute, Open Approach |
| 0YUY0KZ | Supplement Left 5th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUY47Z | Supplement Left 5th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUY4JZ | Supplement Left 5th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUY4KZ | Supplement Left 5th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| X27H385 | Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27H395 | Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27H3B5 | Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27H3C5 | Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J385 | Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27J395 | Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J3B5 | Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J3C5 | Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| XNS0032 | Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 |
| XNS0332 | Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Percutaneous Approach, New Technology Group 2 |
| XNS3032 | Reposition of Cervical Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 |
| XNS3332 | Reposition of Cervical Vertebra using Magnetically Controlled Growth Rod(s), Percutaneous Approach, New Technology Group 2 |
| XNS4032 | Reposition of Thoracic Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 |
| XNS4332 | Reposition of Thoracic Vertebra using Magnetically Controlled Growth Rod(s), Percutaneous Approach, New Technology Group 2 |
| XRG0092 | Fusion of Occipital-cervical Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG00F3 | Fusion of Occipital-cervical Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG1092 | Fusion of Cervical Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG10F3 | Fusion of Cervical Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG2092 | Fusion of 2 or more Cervical Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG20F3 | Fusion of 2 or more Cervical Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG4092 | Fusion of Cervicothoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG40F3 | Fusion of Cervicothoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG6092 | Fusion of Thoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG60F3 | Fusion of Thoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG7092 | Fusion of 2 to 7 Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG70F3 | Fusion of 2 to 7 Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG8092 | Fusion of 8 or more Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG80F3 | Fusion of 8 or more Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGA092 | Fusion of Thoracolumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGA0F3 | Fusion of Thoracolumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGB092 | Fusion of Lumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGB0F3 | Fusion of Lumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGC092 | Fusion of 2 or more Lumbar Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGC0F3 | Fusion of 2 or more Lumbar Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGD092 | Fusion of Lumbosacral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGD0F3 | Fusion of Lumbosacral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
NON-OPERATING ROOM PROCEDURES
| 02H63JZ* | Insertion of Pacemaker Lead into Right Atrium, Percutaneous Approach |
| 02H73JZ* | Insertion of Pacemaker Lead into Left Atrium, Percutaneous Approach |
| 02HK3JZ* | Insertion of Pacemaker Lead into Right Ventricle, Percutaneous Approach |
| 02HL3JZ* | Insertion of Pacemaker Lead into Left Ventricle, Percutaneous Approach |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 14 Apr 2020 14:43:32 CMS, code-revision=250, description-revision=1275 |